Soluble Interleukin 2 Receptor as a Potential Biomarker for Immune Checkpoint Inhibitor Nephritis (ICI-AIN)
Year: 2022
Type: conference-abstract
Institutions: Massachusetts General Hospital, Mayo Clinic
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4397046724
